We substantially invest in RESEARCH and EDUCATION. Unique innovations, such as mucoderm®, maxgraft® bonebuilder and maxresorb® flexbone, the concept of high-quality learning and education with the botiss academy and our international bone & tissue days are the results of our partnership with worldwide renowned academic research institutes, global opinion leaders and practitioners in their daily clinical environment.
Patient’s safety, ease of use, reliable and predictable treatment results – these are your and our first priorities. Providing this through a multitude of preclinical and clinical studies and, most importantly, in the daily clinical work with hundreds of thousands of patients treated worldwide.
botiss’ unique bone regeneration portfolio offers a broad range of reliable treatment possibilities to match the demands of any indication.
botiss biomaterials has vast expertise in the field of soft tissue regeneration and the application of collagen as a biomaterial. botiss’ natural collagen matrices ensure eminent biological activity and compatibility as well as resorption without any residues.